Analytical grade extracts and purified volatile oils batch-tested via GC/HPLC/GC-MS for commercial formulators and nutraceutical contract packagers worldwide.
Gastroesophageal Reflux Disease (GERD) and Functional Dyspepsia (FD) represent interconnected gastrointestinal pathophenotypes affecting over 1.2 billion people globally. While conventional pharmacotherapy heavily emphasizes acid suppression through Proton Pump Inhibitors (PPIs) and Potassium-Competitive Acid Blockers (P-CABs), chronic hypochlorhydria often triggers adverse side effects including dysbiosis, micronutrient malabsorption, and refractory visceral hypersensitivity. Consequently, modern gastroenterological science has pivoted toward phytopharmaceutical therapies that remediate motor function, sensorimotor gating, and mucosal sensitivity without obliterating vital gastric acid secretion.
The combination of pharmaceutical-grade Caraway Oil (Carum carvi L., containing ≥50% (S)-(+)-carvone) and L-Menthol (derived from Mentha arvensis or Mentha piperita, assayed at ≥98% purity) represents the most clinically validated botanical combination for upper gastrointestinal neuromuscular rehabilitation. Rather than working solely as an antacid, this dual botanical system directly modulates gastric tone, fundic accommodation, and sensory nerve excitability in the foregut.
Menthol binds specifically to voltage-gated L-type calcium channels on gastrointestinal smooth muscle cells. This inhibits calcium influx, reducing intracellular free Ca²⁺ and precipitating a rapid, reversible spasmolytic effect throughout the pyloric sphincter and proximal small bowel.
Carvone exerts an antagonistic effect on visceral 5-HT3 and muscarinic receptors within the proximal stomach. By encouraging receptive fundic relaxation without causing gastroparesis, caraway oil decreases intragastric pressure peaks that trigger transient lower esophageal sphincter relaxations (TLESRs).
Menthol acts as an agonist for Transient Receptor Potential Melastatin-8 (TRPM8) receptors on primary afferent nociceptors. Activation induces an anti-hyperalgesic neural gate response, attenuating visceral hypersensitivity, burning retrosternal sensation, and postprandial epigastric pain.
A critical pharmacokinetic paradox lies at the center of caraway and menthol therapy: unformulated menthol administered orally will instantly relax the lower esophageal sphincter (LES), directly provoking severe acid regurgitation and exacerbating GERD episodes. Hence, clinical success hinges upon site-specific enteric formulation. When targeted microencapsulation delays release until the mixture passes beyond the stomach and enters the duodenum and proximal jejunum, systemic vagal reflex loops are triggered that soothe gastric motility upwards without destabilizing the lower esophageal antireflux barrier.
Our vertically integrated extraction park in Jiangxi provides complete traceability from cultivated seed provenance to cGMP pharmacopoeia release.
The botanical extract industry has transitioned from crude, batch-distilled essential oils to molecularly fractionated, standardized active pharmaceutical ingredients (APIs). Jiangxi Baicao Pharmaceutical engineers caraway oil and menthol systems across three distinct technical tiers designed to prevent gastric burst release while optimizing duodenal bioavailability.
| Delivery Platform | Target Release Zone | Polymer / Barrier Matrix | Pharmacokinetic Rationale |
|---|---|---|---|
| Enteric-Coated Softgels | Duodenum (pH ≥ 5.5 - 6.5) | Methacrylic acid copolymers / Ethylcellulose / Sodium alginate | Withstands gastric acid for 120 mins; disintegrates in duodenum within 15-30 minutes, preventing LES relaxation while relaxing pyloric tone. |
| Lipid-Based SEDDS (Self-Emulsifying) | Duodenum & Proximal Jejunum | Caprylic/capric triglycerides + Polysorbate-80 + Phospholipids | Spontaneously creates sub-100nm micelles upon contact with bile fluids, accelerating transcellular absorption of hydrophobic monoterpenes by 340%. |
| Multi-Particulate Sustained Pellets | Duodenum to Terminal Ileum | Fluidized bed aqueous acrylic coatings on microcrystalline cellulose cores | Eliminates all-or-nothing gastric emptying risks; provides constant, continuous delivery over 4 to 8 hours for unvarying visceral analgesia. |
In our advanced continuous rectification facilities, crude caraway steam-distillate undergoes multi-stage fractional vacuum rectification. This separates out the volatile monoterpene fractions (specifically alpha-pinene and beta-myrcene, which cause rancid off-notes and gastric irritation) while concentrating the bio-active (S)-(+)-Carvone to strict pharmacopeial parameters (≥98.0% by GC-FID). Similarly, natural L-menthol is purified through multi-zone temperature-controlled crystallization, securing an enantiopure, crystal structure free of neurotoxic pulegone, menthofuran, and synthetic trace isomers.
Global supply disruptions, fluctuating agrarian yields, and botanical adulteration are primary concerns for pharmaceutical buyers, medical food producers, and dietary supplement brand owners. Jiangxi Baicao Pharmaceutical overcomes these pain points through a fully integrated supply framework situated in the agricultural heartland of Jiangxi, China.
Our raw material base manages thousands of hectares of non-GMO Carum carvi and high-yield Mentha arvensis under strict GAP (Good Agricultural Practices). Batches are monitored for heavy metals, organophosphate pesticides, and soil microbial counts prior to harvest.
Every shipment is subjected to GC-MS enantiomeric analysis, HPLC fingerprint assaying, and ICP-MS heavy metal screening. We provide unambiguous certificates of analysis (COA) confirming zero presence of residual solvents, plasticizers (phthalates), or polycyclic aromatic hydrocarbons (PAHs).
With 12 automated production lines across a 28,600 m² cGMP layout, we retain multi-ton safety buffer stocks of purified bulk carvone and menthol. This mitigates maritime freight bottlenecks, stabilizing long-term contractual pricing for our global enterprise partners.
The global commercial landscape for caraway oil and menthol formulations is rapidly expanding as clinical entities such as FDgard® establish commercial benchmarks in the Medical Foods category. Contract manufacturers and pharmaceutical distributors must navigate distinct regulatory frameworks depending on target geographical jurisdictions:
Governed primarily under FDA 21 CFR 101.9(j)(8) as a Medical Food for the dietary management of Functional Dyspepsia and postprandial distress, or under DSHEA as a dietary supplement. In Canada, formulations qualify as Natural Health Products (NHPs) under NPN monographs requiring validated site licenses.
Recognized as Traditional Herbal Medicinal Products (THMPD) under European Medicines Agency monographs (Carvi aetheroleum and Menthae piperitae aetheroleum). Jiangxi Baicao provides complete European Pharmacopoeia (Ph. Eur.) compliance dossiers and REACH registrations for hassle-free customs clearance.
Expanding across ASEAN, Australia (TGA listed medicines), and domestic Chinese nutraceutical sectors where botanical spasmolytics are integrated into functional beverages, chewable digestive tablets, and dual-phase micro-pellet sachets targeting functional bloating and non-erosive reflux.
Crucial clinical, manufacturing, and regulatory questions answered for R&D scientists, procurement officers, and regulatory affairs directors.
Broaden your active formulation portfolio with our ISO 9001 and cGMP compliant therapeutic and cosmetic essential oils.
Connect directly with Jiangxi Baicao's chemical engineering and regulatory export departments. Secure validated quotation tiers, batch-specific chromatograms, and evaluation sample packs within 24 hours.